Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-04

FDA Approved: TACROLIMUS — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approved a supplemental application for tacrolimus from Quallent Pharmaceuticals Health LLC, granting an additional regulatory action to the existing tacrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)